Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningBone Marrow TransplantationGraft vs Host DiseaseStem Cell TransplantationHematologic NeoplasmsLeukapheresisGranulocyte Colony-Stimulating FactorGraft SurvivalMelphalanAntigens, CD34Blood Component RemovalTissue DonorsCombined Modality TherapyTreatment OutcomeCyclophosphamideHematopoietic Stem CellsBusulfanMultiple MyelomaMyeloablative AgonistsAntineoplastic Combined Chemotherapy ProtocolsStem CellsTransplantation ChimeraCord Blood Stem Cell TransplantationRecurrenceBone MarrowWhole-Body IrradiationRemission InductionLymphoma, Non-HodgkinLiver TransplantationHistocompatibilityHistocompatibility TestingRetrospective StudiesAntineoplastic Agents, AlkylatingKidney TransplantationEtoposideImmunosuppressive AgentsLeukemiaThiotepaPOEMS SyndromeDisease-Free SurvivalTransplantation, IsogeneicTime FactorsInfectionHematopoiesisTissue and Organ ProcurementBone Marrow CellsSurvival AnalysisVidarabineSurvival RateAnemia, AplasticLiving DonorsCytomegalovirus InfectionsLeukemia, Myeloid, AcuteSalvage TherapyAmyloidosisBlood CellsHodgkin DiseaseGraft vs Leukemia EffectIfosfamideOrgan TransplantationVincristineCytarabineCarmustinePlatelet CountTransplantationMyelodysplastic SyndromesMedical TourismLeukemia, Myelogenous, Chronic, BCR-ABL PositiveOpportunistic InfectionsLymphocyte DepletionCyclosporineFatal OutcomeImmunosuppressionLymphomaBlood Cell CountFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesNeoplasmsHLA AntigensLung TransplantationBone Marrow PurgingCytophagocytosisFeasibility StudiesGraft RejectionBone Marrow DiseasesHistiocytosis, Non-Langerhans-CellProspective StudiesImmunophenotypingBlood DonorsLivedo ReticularisDoxorubicinPilot ProjectsRecombinant ProteinsBlood Group Incompatibility